Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
33
HELE Quote, Financials, Valuation and Earnings
Last price:
$20.58
Seasonality move
:
4.75%
Day range:
$20.31 - $22.35
52-week range:
$17.01 - $69.05
Dividend yield:
0%
P/E ratio:
4.45x
P/S ratio:
0.27x
P/B ratio:
0.52x
Volume:
1M
Avg. volume:
926.3K
1-year change:
-64.45%
Market cap:
$485.4M
Revenue:
$1.9B
EPS (TTM):
-$28.70
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HELE
Helen of Troy Ltd.
|
$502.2M | $1.68 | -5.33% | -22.05% | $29.33 |
|
EL
The Estée Lauder Companies, Inc.
|
$4.2B | $0.83 | 5.47% | -65.79% | $106.29 |
|
EWCZ
European Wax Center, Inc.
|
$47.6M | $0.04 | -4.36% | -13.39% | $6.68 |
|
KVUE
Kenvue, Inc.
|
$3.7B | $0.23 | 1.17% | 49.81% | $19.33 |
|
SKIN
The Beauty Health Co.
|
$77.7M | -$0.05 | -6.95% | -66.08% | $1.93 |
|
SLSN
Solesence, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HELE
Helen of Troy Ltd.
|
$21.08 | $29.33 | $485.4M | 4.45x | $0.00 | 0% | 0.27x |
|
EL
The Estée Lauder Companies, Inc.
|
$105.27 | $106.29 | $37.9B | 124.05x | $0.35 | 1.33% | 2.64x |
|
EWCZ
European Wax Center, Inc.
|
$4.03 | $6.68 | $176.1M | 15.45x | $0.00 | 0% | 0.83x |
|
KVUE
Kenvue, Inc.
|
$16.74 | $19.33 | $32.1B | 22.50x | $0.21 | 4.93% | 2.15x |
|
SKIN
The Beauty Health Co.
|
$1.44 | $1.93 | $183.6M | -- | $0.00 | 0% | 0.62x |
|
SLSN
Solesence, Inc.
|
$1.50 | -- | $105.8M | 107.14x | $0.00 | 0% | 1.72x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HELE
Helen of Troy Ltd.
|
50.17% | 0.995 | 165.45% | 0.69x |
|
EL
The Estée Lauder Companies, Inc.
|
70.78% | 2.387 | 29.67% | 0.81x |
|
EWCZ
European Wax Center, Inc.
|
83.03% | 5.898 | 191.37% | 2.95x |
|
KVUE
Kenvue, Inc.
|
46.14% | -1.442 | 29.3% | 0.58x |
|
SKIN
The Beauty Health Co.
|
85.23% | 4.579 | 149.6% | 4.02x |
|
SLSN
Solesence, Inc.
|
59.38% | 2.975 | 11.09% | 0.66x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HELE
Helen of Troy Ltd.
|
$192.5M | $16M | -28.98% | -46.84% | 3.7% | -$21.9M |
|
EL
The Estée Lauder Companies, Inc.
|
$2.6B | $231M | -6.74% | -21.78% | 6.64% | -$436M |
|
EWCZ
European Wax Center, Inc.
|
$34.7M | $14.3M | 3.41% | 16.45% | 26.36% | $16.5M |
|
KVUE
Kenvue, Inc.
|
$2.2B | $713M | 7.47% | 13.85% | 18.95% | $196M |
|
SKIN
The Beauty Health Co.
|
$45.6M | -$6.2M | -2.13% | -19.76% | -8.84% | $8.6M |
|
SLSN
Solesence, Inc.
|
$3.4M | -$781K | 2.86% | 6.62% | -5.35% | -$2.9M |
Helen of Troy Ltd. vs. Competitors
-
Which has Higher Returns HELE or EL?
The Estée Lauder Companies, Inc. has a net margin of -71.19% compared to Helen of Troy Ltd.'s net margin of 1.35%. Helen of Troy Ltd.'s return on equity of -46.84% beat The Estée Lauder Companies, Inc.'s return on equity of -21.78%.
Company Gross Margin Earnings Per Share Invested Capital HELEHelen of Troy Ltd.44.39% -$13.44 $1.9B ELThe Estée Lauder Companies, Inc.73.37% $0.13 $13.3B -
What do Analysts Say About HELE or EL?
Helen of Troy Ltd. has a consensus price target of $29.33, signalling upside risk potential of 39.15%. On the other hand The Estée Lauder Companies, Inc. has an analysts' consensus of $106.29 which suggests that it could grow by 0.97%. Given that Helen of Troy Ltd. has higher upside potential than The Estée Lauder Companies, Inc., analysts believe Helen of Troy Ltd. is more attractive than The Estée Lauder Companies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HELEHelen of Troy Ltd.0 4 0 ELThe Estée Lauder Companies, Inc.7 15 1 -
Is HELE or EL More Risky?
Helen of Troy Ltd. has a beta of 0.782, which suggesting that the stock is 21.789% less volatile than S&P 500. In comparison The Estée Lauder Companies, Inc. has a beta of 1.153, suggesting its more volatile than the S&P 500 by 15.294%.
-
Which is a Better Dividend Stock HELE or EL?
Helen of Troy Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Estée Lauder Companies, Inc. offers a yield of 1.33% to investors and pays a quarterly dividend of $0.35 per share. Helen of Troy Ltd. pays -- of its earnings as a dividend. The Estée Lauder Companies, Inc. pays out 54.55% of its earnings as a dividend. The Estée Lauder Companies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios HELE or EL?
Helen of Troy Ltd. quarterly revenues are $433.6M, which are smaller than The Estée Lauder Companies, Inc. quarterly revenues of $3.5B. Helen of Troy Ltd.'s net income of -$308.6M is lower than The Estée Lauder Companies, Inc.'s net income of $47M. Notably, Helen of Troy Ltd.'s price-to-earnings ratio is 4.45x while The Estée Lauder Companies, Inc.'s PE ratio is 124.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen of Troy Ltd. is 0.27x versus 2.64x for The Estée Lauder Companies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HELEHelen of Troy Ltd.0.27x 4.45x $433.6M -$308.6M ELThe Estée Lauder Companies, Inc.2.64x 124.05x $3.5B $47M
-
Which has Higher Returns HELE or EWCZ?
European Wax Center, Inc. has a net margin of -71.19% compared to Helen of Troy Ltd.'s net margin of 9.91%. Helen of Troy Ltd.'s return on equity of -46.84% beat European Wax Center, Inc.'s return on equity of 16.45%.
Company Gross Margin Earnings Per Share Invested Capital HELEHelen of Troy Ltd.44.39% -$13.44 $1.9B EWCZEuropean Wax Center, Inc.63.98% $0.09 $487M -
What do Analysts Say About HELE or EWCZ?
Helen of Troy Ltd. has a consensus price target of $29.33, signalling upside risk potential of 39.15%. On the other hand European Wax Center, Inc. has an analysts' consensus of $6.68 which suggests that it could grow by 65.84%. Given that European Wax Center, Inc. has higher upside potential than Helen of Troy Ltd., analysts believe European Wax Center, Inc. is more attractive than Helen of Troy Ltd..
Company Buy Ratings Hold Ratings Sell Ratings HELEHelen of Troy Ltd.0 4 0 EWCZEuropean Wax Center, Inc.2 4 1 -
Is HELE or EWCZ More Risky?
Helen of Troy Ltd. has a beta of 0.782, which suggesting that the stock is 21.789% less volatile than S&P 500. In comparison European Wax Center, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HELE or EWCZ?
Helen of Troy Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen of Troy Ltd. pays -- of its earnings as a dividend. European Wax Center, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HELE or EWCZ?
Helen of Troy Ltd. quarterly revenues are $433.6M, which are larger than European Wax Center, Inc. quarterly revenues of $54.2M. Helen of Troy Ltd.'s net income of -$308.6M is lower than European Wax Center, Inc.'s net income of $5.4M. Notably, Helen of Troy Ltd.'s price-to-earnings ratio is 4.45x while European Wax Center, Inc.'s PE ratio is 15.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen of Troy Ltd. is 0.27x versus 0.83x for European Wax Center, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HELEHelen of Troy Ltd.0.27x 4.45x $433.6M -$308.6M EWCZEuropean Wax Center, Inc.0.83x 15.45x $54.2M $5.4M
-
Which has Higher Returns HELE or KVUE?
Kenvue, Inc. has a net margin of -71.19% compared to Helen of Troy Ltd.'s net margin of 10.58%. Helen of Troy Ltd.'s return on equity of -46.84% beat Kenvue, Inc.'s return on equity of 13.85%.
Company Gross Margin Earnings Per Share Invested Capital HELEHelen of Troy Ltd.44.39% -$13.44 $1.9B KVUEKenvue, Inc.59% $0.21 $19.7B -
What do Analysts Say About HELE or KVUE?
Helen of Troy Ltd. has a consensus price target of $29.33, signalling upside risk potential of 39.15%. On the other hand Kenvue, Inc. has an analysts' consensus of $19.33 which suggests that it could grow by 15.49%. Given that Helen of Troy Ltd. has higher upside potential than Kenvue, Inc., analysts believe Helen of Troy Ltd. is more attractive than Kenvue, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HELEHelen of Troy Ltd.0 4 0 KVUEKenvue, Inc.2 11 0 -
Is HELE or KVUE More Risky?
Helen of Troy Ltd. has a beta of 0.782, which suggesting that the stock is 21.789% less volatile than S&P 500. In comparison Kenvue, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HELE or KVUE?
Helen of Troy Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue, Inc. offers a yield of 4.93% to investors and pays a quarterly dividend of $0.21 per share. Helen of Troy Ltd. pays -- of its earnings as a dividend. Kenvue, Inc. pays out 150.5% of its earnings as a dividend.
-
Which has Better Financial Ratios HELE or KVUE?
Helen of Troy Ltd. quarterly revenues are $433.6M, which are smaller than Kenvue, Inc. quarterly revenues of $3.8B. Helen of Troy Ltd.'s net income of -$308.6M is lower than Kenvue, Inc.'s net income of $398M. Notably, Helen of Troy Ltd.'s price-to-earnings ratio is 4.45x while Kenvue, Inc.'s PE ratio is 22.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen of Troy Ltd. is 0.27x versus 2.15x for Kenvue, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HELEHelen of Troy Ltd.0.27x 4.45x $433.6M -$308.6M KVUEKenvue, Inc.2.15x 22.50x $3.8B $398M
-
Which has Higher Returns HELE or SKIN?
The Beauty Health Co. has a net margin of -71.19% compared to Helen of Troy Ltd.'s net margin of -15.61%. Helen of Troy Ltd.'s return on equity of -46.84% beat The Beauty Health Co.'s return on equity of -19.76%.
Company Gross Margin Earnings Per Share Invested Capital HELEHelen of Troy Ltd.44.39% -$13.44 $1.9B SKINThe Beauty Health Co.64.59% -$0.09 $444.6M -
What do Analysts Say About HELE or SKIN?
Helen of Troy Ltd. has a consensus price target of $29.33, signalling upside risk potential of 39.15%. On the other hand The Beauty Health Co. has an analysts' consensus of $1.93 which suggests that it could grow by 34.26%. Given that Helen of Troy Ltd. has higher upside potential than The Beauty Health Co., analysts believe Helen of Troy Ltd. is more attractive than The Beauty Health Co..
Company Buy Ratings Hold Ratings Sell Ratings HELEHelen of Troy Ltd.0 4 0 SKINThe Beauty Health Co.1 6 0 -
Is HELE or SKIN More Risky?
Helen of Troy Ltd. has a beta of 0.782, which suggesting that the stock is 21.789% less volatile than S&P 500. In comparison The Beauty Health Co. has a beta of 1.162, suggesting its more volatile than the S&P 500 by 16.231%.
-
Which is a Better Dividend Stock HELE or SKIN?
Helen of Troy Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen of Troy Ltd. pays -- of its earnings as a dividend. The Beauty Health Co. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HELE or SKIN?
Helen of Troy Ltd. quarterly revenues are $433.6M, which are larger than The Beauty Health Co. quarterly revenues of $70.7M. Helen of Troy Ltd.'s net income of -$308.6M is lower than The Beauty Health Co.'s net income of -$11M. Notably, Helen of Troy Ltd.'s price-to-earnings ratio is 4.45x while The Beauty Health Co.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen of Troy Ltd. is 0.27x versus 0.62x for The Beauty Health Co.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HELEHelen of Troy Ltd.0.27x 4.45x $433.6M -$308.6M SKINThe Beauty Health Co.0.62x -- $70.7M -$11M
-
Which has Higher Returns HELE or SLSN?
Solesence, Inc. has a net margin of -71.19% compared to Helen of Troy Ltd.'s net margin of -7.67%. Helen of Troy Ltd.'s return on equity of -46.84% beat Solesence, Inc.'s return on equity of 6.62%.
Company Gross Margin Earnings Per Share Invested Capital HELEHelen of Troy Ltd.44.39% -$13.44 $1.9B SLSNSolesence, Inc.23.09% -$0.02 $42.4M -
What do Analysts Say About HELE or SLSN?
Helen of Troy Ltd. has a consensus price target of $29.33, signalling upside risk potential of 39.15%. On the other hand Solesence, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Helen of Troy Ltd. has higher upside potential than Solesence, Inc., analysts believe Helen of Troy Ltd. is more attractive than Solesence, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HELEHelen of Troy Ltd.0 4 0 SLSNSolesence, Inc.0 0 0 -
Is HELE or SLSN More Risky?
Helen of Troy Ltd. has a beta of 0.782, which suggesting that the stock is 21.789% less volatile than S&P 500. In comparison Solesence, Inc. has a beta of 1.083, suggesting its more volatile than the S&P 500 by 8.259%.
-
Which is a Better Dividend Stock HELE or SLSN?
Helen of Troy Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solesence, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen of Troy Ltd. pays -- of its earnings as a dividend. Solesence, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HELE or SLSN?
Helen of Troy Ltd. quarterly revenues are $433.6M, which are larger than Solesence, Inc. quarterly revenues of $14.6M. Helen of Troy Ltd.'s net income of -$308.6M is lower than Solesence, Inc.'s net income of -$1.1M. Notably, Helen of Troy Ltd.'s price-to-earnings ratio is 4.45x while Solesence, Inc.'s PE ratio is 107.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen of Troy Ltd. is 0.27x versus 1.72x for Solesence, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HELEHelen of Troy Ltd.0.27x 4.45x $433.6M -$308.6M SLSNSolesence, Inc.1.72x 107.14x $14.6M -$1.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
70
RGC alert for Jan 8
Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.
Buy
64
RVMD alert for Jan 8
Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.
Sell
38
CRNX alert for Jan 8
Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.
